{
  "actions": [
    {
      "acted_at": "2020-03-03",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2020-03-03",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s3384-116",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "116",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-03-03",
  "number": "3384",
  "official_title": "A bill to allow for negotiation of prices for certain covered Medicare part D drugs, to allow for importation by individuals of prescription drugs from Canada, to preserve access to affordable generics and biosimilars, to increase the use of real-time benefit tools to lower beneficiary costs, to establish a manufacturer discount program, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr478-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "hr2374-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "hr2455-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "s61-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "s64-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "s1169-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "s1224-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Lowering Prescription Drug Prices for America\u00e2\u20ac\u2122s Seniors and Families Act of 2020",
  "sponsor": {
    "bioguide_id": "M001197",
    "district": null,
    "name": "McSally, Martha",
    "state": "AZ",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-03-03",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Administrative remedies",
    "Business ethics",
    "Canada",
    "Civil actions and liability",
    "Competition and antitrust",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Federal Trade Commission (FTC)",
    "Food and Drug Administration (FDA)",
    "Government information and archives",
    "Health",
    "Health care costs and insurance",
    "Health information and medical records",
    "Inflation and prices",
    "Intellectual property",
    "Licensing and registrations",
    "Manufacturing",
    "Medicare",
    "Prescription drugs",
    "Public participation and lobbying",
    "Trade restrictions"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2020-03-03",
    "date": "2021-01-11T22:09:46Z",
    "text": "Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020\n\nThis bill makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Lowering Prescription Drug Prices for America\u00e2\u20ac\u2122s Seniors and Families Act of 2020",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Lowering Prescription Drug Prices for America\u00e2\u20ac\u2122s Seniors and Families Act of 2020",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to allow for negotiation of prices for certain covered Medicare part D drugs, to allow for importation by individuals of prescription drugs from Canada, to preserve access to affordable generics and biosimilars, to increase the use of real-time benefit tools to lower beneficiary costs, to establish a manufacturer discount program, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2022-02-08T23:23:00Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s3384.xml"
}